Flamdir-SP Tablet is a combination medication containing Aceclofenac (100mg), Paracetamol (325mg), and Serratiopeptidase (15mg), designed to provide effective relief from pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), works by inhibiting cyclooxygenase enzymes, thereby reducing the production of prostaglandins responsible for pain and inflammation. Paracetamol acts as an analgesic and antipyretic, helping to alleviate mild to moderate pain and reduce fever. Serratiopeptidase is a proteolytic enzyme that aids in breaking down inflammatory mediators and promotes the reduction of swelling and edema. Together, these components offer a synergistic effect, making Flamdir-SP Tablet suitable for managing conditions such as osteoarthritis, rheumatoid arthritis, musculoskeletal injuries, postoperative pain, and other inflammatory disorders. The combination ensures rapid pain relief while minimizing inflammation and associated discomfort. It is typically prescribed for short-term use under medical supervision, and patients should adhere to the recommended dosage to avoid potential side effects such as gastrointestinal irritation or allergic reactions. Flamdir-SP Tablet should be taken with food to reduce the risk of stomach upset, and it is contraindicated in individuals with known hypersensitivity to any of its components or with certain medical conditions like peptic ulcers or severe liver impairment.